What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Endocrinology
His primary areas of study are Internal medicine, Endocrinology, Acromegaly, Hormone and Somatostatin.
Lawrence A. Frohman regularly links together related areas like Loss of heterozygosity in his Internal medicine studies.
His work on Endocrinology deals in particular with Growth hormone secretion, Hypothalamus, Growth hormone–releasing hormone, Peptide hormone and Insulin.
His Acromegaly research is multidisciplinary, incorporating perspectives in Tumor suppressor gene, Complication, Chemotherapy and Adenoma.
His studies in Hormone integrate themes in fields like Secretion and Stimulation.
His biological study deals with issues like Anterior pituitary, which deal with fields such as Gonadotropic cell.
His most cited work include:
- Enhanced Growth of Mice Lacking the Cyclin-Dependent Kinase Inhibitor Function of p27Kip1 (1184 citations)
- Criteria for cure of acromegaly: a consensus statement. (895 citations)
- Somatomedin-C mediates growth hormone negative feedback by effects on both the hypothalamus and the pituitary (748 citations)
What are the main themes of his work throughout his whole career to date?
Lawrence A. Frohman mainly investigates Internal medicine, Endocrinology, Somatostatin, Hormone and Growth hormone secretion.
All of his Internal medicine and Acromegaly, Peptide hormone, Somatropin, Secretion and Receptor investigations are sub-components of the entire Internal medicine study.
Hypothalamus, Pituitary gland, Growth hormone–releasing hormone, Somatotropic cell and Insulin are subfields of Endocrinology in which his conducts study.
His Somatostatin research is multidisciplinary, incorporating elements of Neuropeptide, Growth factor, Somatomedin and Gonadotropic cell.
Lawrence A. Frohman has included themes like Messenger RNA and Thyroid in his Hormone study.
His Growth hormone secretion research includes themes of Thyrotropin-releasing hormone, Blood sampling and Stimulation.
He most often published in these fields:
- Internal medicine (80.45%)
- Endocrinology (76.36%)
- Somatostatin (26.82%)
What were the highlights of his more recent work (between 2004-2020)?
- Internal medicine (80.45%)
- Endocrinology (76.36%)
- Acromegaly (15.45%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Internal medicine, Endocrinology, Acromegaly, Growth hormone secretion and Context.
In Internal medicine, Lawrence A. Frohman works on issues like Gastroenterology, which are connected to Octreotide acetate.
His study in Hormone, CJC-1295, Growth hormone–releasing hormone, Somatostatin and Pituitary gland falls under the purview of Endocrinology.
Lawrence A. Frohman has researched Growth hormone–releasing hormone in several fields, including Receptor and Somatotropic cell.
His Somatostatin research is multidisciplinary, relying on both Hypothalamic Hormones and Argument.
His Acromegaly study combines topics from a wide range of disciplines, such as Multiple endocrine neoplasia, Octreotide, Cell growth and Pathology.
Between 2004 and 2020, his most popular works were:
- Treatment of Pituitary-Dependent Cushing’s Disease with the Multireceptor Ligand Somatostatin Analog Pasireotide (SOM230): A Multicenter, Phase II Trial (245 citations)
- The Role of the Aryl Hydrocarbon Receptor-Interacting Protein Gene in Familial and Sporadic Pituitary Adenomas (241 citations)
- Consensus statement: medical management of acromegaly (212 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Enzyme
His primary scientific interests are in Internal medicine, Endocrinology, Acromegaly, Context and Pituitary adenoma.
His CJC-1295, Pituitary gland, Hormone, Growth hormone secretion and Clinical trial investigations are all subjects of Internal medicine research.
His biological study spans a wide range of topics, including Hypothalamus, Pulsatile flow, Hormone analog, Blood sampling and Peptide hormone.
The various areas that Lawrence A. Frohman examines in his Endocrinology study include Multiple endocrine neoplasia and Prior Radiotherapy.
His Acromegaly study combines topics in areas such as Alternative medicine and MEDLINE.
His Pituitary adenoma research focuses on Tumor suppressor gene and how it connects with MEN1, HEK 293 cells and Cell growth.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
